𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combined Cetuximab and Reirradiation for Locoregional Recurrent and Inoperable Squamous Cell Carcinoma of the Head and Neck

✍ Scribed by Panagiotis Balermpas; Markus Hambek; Oliver Seitz; Claus Rödel; Christian Weiss

Publisher
Springer
Year
2009
Tongue
German
Weight
308 KB
Volume
185
Category
Article
ISSN
0179-7158

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Soluble Tie-2 receptor levels independen
Soluble Tie-2 receptor levels independently predict locoregional recurrence in head and neck squamous cell carcinoma
✍ Jarrod J. Homer; John Greenman; Joachim Drevs; Dieter Marme; Nicholas D. Staffor 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

## Abstract ## Background This study assessed two circulating angiogenic receptors as tumor markers in patients with head and neck squamous cell carcinoma (HNSCC): soluble vascular endothelial factor growth receptor‐1 (sVEGFR1) and soluble Tie‐2 receptor (sTie2R). ## Methods Sera from 79 newly p

Combination chemotherapy for advanced sq
Combination chemotherapy for advanced squamous cell carcinoma of the head and neck
✍ Coker, Donald D. ;Elias, E. George ;Chretien, Paul B. ;Gray, William C. ;Coleman 📂 Article 📅 1981 🏛 Wiley (John Wiley & Sons) ⚖ 639 KB

## Abstract Fifty‐one patients (32 previously untreated, 19 previously treated) with advanced squamous cell carcinoma of the head and neck received a single course of combination chemotherapy consisting of high dose __cis__‐platinum (DDP), bleomycin (Bleo), ± high dose methotrexate (MTX). Thirty‐th

Time to recurrence of squamous cell carc
Time to recurrence of squamous cell carcinoma of the head and neck
✍ Professor Philip M. Stell 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 2 views

A personal series of 3,215 patients with proven squamous cell carcinoma of the mucosal surfaces of the upper aerodigestive tract is presented. Of these patients, 515 suffered a recurrence of their primary tumor after a course of radiotherapy. The time from the end of radiotherapy to diagnosis of a p